Skip to main content

Japan's Takeda Pharma to restructure after annual profit slump

By Reuters  
   May 10, 2024

Japan's biggest drugmaker said it will incur restructuring costs of about 140 billion yen ($899 million) this fiscal year as part of a plan to optimise its workforce, cut costs and strengthen technology

Full story

Get the latest on healthcare leadership in your inbox.